Air Pollution and Cardiometabolic Study

April 3, 2018 updated by: WeiHuang

Characterization and Health Risk Assessment of Exposure to Source-Specific PM2.5 in Subjects in Beijing

The study mainly focuse on examining the subjects living in traffic polluted area and assessing the popuation health risk using disease and risk assessment models.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Beijing
      • Beijing, Beijing, China, 100191
        • Peking University ,School of Public Health
      • Beijing, Beijing, China, 100191
        • Peking University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Living in PU community neighborhood,Beijing, China

Description

Inclusion Criteria:

  • Living in PU community neighborhood，Non smoker and No diseases ,and so on.

Exclusion Criteria:

  • Advanced microvascular or neuropathic complications and active cardiovascular disease,and so on.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vascular endothelial function
Time Frame: Four months
Vascular endothelial function measured by Endo-PAT2000
Four months
Arrythmias
Time Frame: Four months
Twenty four-hour electrocardiograms
Four months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
System inflammatory
Time Frame: Four months
Analyzed systemic inflammation biomarkers,such as C-reaction Protein and Blood coagulation by ELISA
Four months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

WeiHuang

Investigators

  • Principal Investigator: Wei Huang, PhD, Peking University School of Public Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

November 3, 2015

First Submitted That Met QC Criteria

November 9, 2015

First Posted (Estimate)

November 10, 2015

Study Record Updates

Last Update Posted (Actual)

April 5, 2018

Last Update Submitted That Met QC Criteria

April 3, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • WHuang15_17

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Outcomes

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe